Jithendra Chimakurthy

6PUBLICATIONS
9CO-AUTHORS
Molecular targetsPharmaceutical delivery technologiesNutritional science
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 28, 2026
Simultaneous Estimation of Avutometinib and Defactinib in Rat Plasma by Using LC-MS/MS and Its Application to Pharmacokinetic Studies.

|May 26, 2026
Preclinical Pharmacokinetics of Erdafitinib, an FGFR Tyrosine Kinase Inhibitor, via LC-MS/MS in Sprague Dawley Rats.

|Nov 30, 2025
Validated LC-MS/MS Method for the Quantitative Determination and Pharmacokinetic Profiling of Fedratinib (TG101348), an Oral JAK2 Inhibitor, in CD1 Mice Plasma.

Rajesh Kumar Boggavarapu, Vishwottam Kandikere, Jithendra Chimakurthy

|Dec 19, 2024
Quantification of Vactosertib an Inhibitor of TGFBR1 by LC-MS/MS in Rat Plasma and Its Pharmacokinetic Profiling.

Rajesh Kumar Boggavarapu, Jithendra Chimakurthy, Sathish Kumar Konidala

|Dec 22, 2022
Emerging Role of Biopharmaceutical Classification and Biopharmaceutical Drug Disposition System in Dosage form Development: A Systematic Review.

Ramu Samineni, Jithendra Chimakurthy, Sathish Konidala

|Sep 07, 2021
The role of body mass index or metabolic syndrome components causing depression in women: An observation from weight reduction clinical trial.

Ranakishor Pelluri, Srikanth Kongara, Jithendra Chimakurthy

Pageof 1

Frequent Collaborators

2 joint publications

Sathish Kumar Konidala

1 joint publications

Ranakishor Pelluri

1 joint publications

Srikanth Kongara

1 joint publications

Shriraam Mahadevan